Fosamax Plus D Merck & Co., Inc. - Treatment for Osteoporosis

Fosamax Plus D is a single once-weekly tablet containing the bisphosphonate drug alendronate, and seven days’ worth of vitamin D, an essential nutrient required for calcium absorption. Fosamax Plus D is used to reduce the risk of hip and spinal fractures in postmenopausal women with osteoporosis, and to increase bone mass in men with osteoporosis.

Posted: April 2005

Fosamax Plus D (alendronate and cholecalciferol) FDA Approval History

View comments

Hide
(web5)